WGS allows for the identification of novel genetic mutations and variants that may contribute to cancer. By understanding these genetic alterations, researchers can gain insights into the mechanisms driving cancer, identify potential biomarkers for diagnosis and prognosis, and discover new therapeutic targets. It also facilitates the study of tumor heterogeneity and clonal evolution, which are critical for understanding treatment resistance and disease progression.
